Literature DB >> 20644902

[Dermatologic aspects of anticoagulation].

V Meyer1, S W Schneider, T Görge.   

Abstract

The coagulation system protects the body from uncontrolled blood loss by means of highly regulated processes. In case of an injury the coagulation system instantly switches from controlled blood flow to acute coagulation and thrombus formation with the goal of stopping the blood loss. Minor changes in this well-maintained equilibrium of coagulation and blood flow tip the balance towards uncontrolled blood loss or even fatal thromboembolic events. Iatrogenic manipulation of this highly regulated system is possible with a variety of therapeutic agents. We review the basics of coagulation physiology and then discuss dermatologically relevant aspects of thrombosis prevention, as well as the use of anticoagulants to treat dermatologic diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20644902     DOI： 10.1007/s00105-010-1996-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  37 in total

1.  Preparation of heparin and its use in the first clinical cases.

Authors:  C H BEST
Journal:  Circulation       Date:  1959-01       Impact factor: 29.690

2.  Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin.

Authors:  A K Chauhan; T Goerge; S W Schneider; D D Wagner
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

3.  Multiple cardiac metastases from a malignant melanoma causing consecutive pulmonary embolism.

Authors:  Sebastian Machnick; Thomas Butz; Marc van Bracht; Christian Zühlke; Gunnar Plehn; Hakan Yeni; Axel Meissner; Hans-Joachim Trappe
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

4.  Incidence of deep venous thrombosis in patients with erysipelas of the leg: prospective study of 30 cases in an emergency department.

Authors:  Imen Zaghdoudi; Monia Rezgui; Wathak Zouaoui; Takoua Marhbene; Ali Jendoubi; Rim El Fatimi; Nébiha Borsali-Falfoul; Mohamed Habib Daghfous; Zouhair Jerbi
Journal:  Pathophysiol Haemost Thromb       Date:  2009-12-09

5.  Studies on the Hemorrhagic Agent 3,3'-Methylenebis (4-Hydroxycoumarin): IV. The Pathologic Findings after the Administration of Dicumarol.

Authors:  J C McCarter; J B Bingham; O O Meyer
Journal:  Am J Pathol       Date:  1944-05       Impact factor: 4.307

6.  Risk factors for delayed healing and recurrence of chronic venous leg ulcers--an analysis of 1324 legs.

Authors:  M S Gohel; M Taylor; J J Earnshaw; B P Heather; K R Poskitt; M R Whyman
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-01       Impact factor: 7.069

7.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers.

Authors:  S W Schneider; S Nuschele; A Wixforth; C Gorzelanny; A Alexander-Katz; R R Netz; M F Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

Review 8.  Arterial tumor embolism caused by metastatic melanoma: case report and literature review.

Authors:  Marcello U Grazziotin; William D Turnipseed
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

Review 9.  Role of tissue factor in cancer.

Authors:  Raj S Kasthuri; Mark B Taubman; Nigel Mackman
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

10.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Authors:  M Levine; M Gent; J Hirsh; J Leclerc; D Anderson; J Weitz; J Ginsberg; A G Turpie; C Demers; M Kovacs
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245
View more
  1 in total

Review 1.  [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].

Authors:  T Goerge
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.